160 filings
Page 3 of 8
6-K
0eu8rx daqzm8x
10 Apr 23
Current Report
5:23pm
6-K
5lgqz p9m
10 Apr 23
Report of Foreign Private Issuer
6:04am
6-K
igy882ka65
6 Apr 23
AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct Offering
8:17pm
6-K/A
b2tg74sx
5 Apr 23
Current report (foreign) (amended)
11:54am
6-K
wjcl6rtyghifu6v72q
4 Apr 23
Report of Foreign Private Issuer
5:24pm
424B5
cswvlymbh
4 Apr 23
Prospectus supplement for primary offering
5:23pm
6-K
1de7fg8ai4v
31 Mar 23
AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering
9:41pm
6-K
2rjxq
23 Mar 23
Current report (foreign)
8:57am
6-K
1orfbb
20 Mar 23
Current report (foreign)
6:25am
6-K
qsirurndtg
7 Mar 23
Report of Foreign Private Issuer
6:08am
6-K
rugf1hqry6pghyh c2
6 Mar 23
AnPac Bio-Medical Science Announces US$5 Million Private Placement
8:30am
6-K
cv0fh546 xl
15 Feb 23
AnPac Bio-Medical Science Acquires GISN (HK) LIMITED, a Technical Solution and Outsourcing Consulting Services Provider
8:30am
6-K
4glsbr
13 Feb 23
Current report (foreign)
8:30am
6-K
ccptz
9 Feb 23
AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce Platform
8:30am
6-K
dypzi01ea0fo6m ec
27 Jan 23
AnPac Bio-Medical Science Announces Signing of US$5.2 Million of Definitive Investment Agreements
4:30pm
6-K
rfmgr voszr
24 Jan 23
Current report (foreign)
7:21am
6-K
fdxa9t
20 Jan 23
Current report (foreign)
4:31pm
6-K
orcqs98fdnh525i4i
20 Jan 23
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
4:30pm
6-K
2akud8
29 Dec 22
Current report (foreign)
6:02am
6-K
akx55z 0un7sy
16 Dec 22
AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022
5:01pm